Mark Luz
Corporate Officer/Principal bei TARSUS PHARMACEUTICALS, INC.
Aktive Positionen von Mark Luz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Karriereverlauf von Mark Luz
Ehemalige bekannte Positionen von Mark Luz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | - | - |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Corporate Officer/Principal | - | - |
Ausbildung von Mark Luz
| Arizona State University | Undergraduate Degree |
| University of Southern California | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TARSUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Health Technology |
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
